FSD Pharma Inc. (HUGE.CN)
- Previous Close
0.6400 - Open
0.6400 - Bid 0.6300 x --
- Ask 0.6500 x --
- Day's Range
0.6400 - 0.6400 - 52 Week Range
0.5800 - 2.2300 - Volume
700 - Avg. Volume
37,960 - Market Cap (intraday)
25.875M - Beta (5Y Monthly) 0.91
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6400 - Earnings Date May 10, 2024 - May 14, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.
www.fsdpharma.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: HUGE.CN
Performance Overview: HUGE.CN
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HUGE.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HUGE.CN
Valuation Measures
Market Cap
25.87M
Enterprise Value
21.50M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.41
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-1.37
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-43.02%
Return on Equity (ttm)
-83.91%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-17.9M
Diluted EPS (ttm)
-0.6400
Balance Sheet and Cash Flow
Total Cash (mrq)
3.51M
Total Debt/Equity (mrq)
2.63%
Levered Free Cash Flow (ttm)
-15.51M